taxonomy (1)
protein (1)
source (3)
structure (0)
composition (36)
disease (2)
reference (3)
site (1)
peptide (1)
- Homo sapiens (Human)
Taxonomy
Reported structure
- Hex:3 HexNAc:2 dHex:1 (avg mass : 1056.9755 )
- Hex:3 HexNAc:3 dHex:1 (avg mass : 1260.1705 )
- Hex:3 HexNAc:4 (avg mass : 1317.2225 )
- Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
- Hex:3 HexNAc:5 (avg mass : 1520.4175 )
- Hex:3 HexNAc:5 dHex:1 (avg mass : 1666.5605 )
- Hex:3 HexNAc:6 dHex:2 NeuAc:1 (avg mass : 2307.1564 )
- Hex:4 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 1713.5708 )
- Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 1916.7658 )
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2062.9088 )
- Hex:4 HexNAc:5 (avg mass : 1682.5599 )
- Hex:4 HexNAc:5 NeuAc:1 NeuGc:1 (avg mass : 2281.0751 )
- Hex:4 HexNAc:5 dHex:1 (avg mass : 1828.7029 )
- Hex:4 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2119.9608 )
- Hex:4 HexNAc:5 dHex:2 NeuAc:1 (avg mass : 2266.1038 )
- Hex:4 HexNAc:6 dHex:1 (avg mass : 2031.8979 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:5 NeuAc:1 (avg mass : 2135.9602 )
- Hex:5 HexNAc:5 dHex:1 (avg mass : 1990.8453 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2282.1032 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2573.3611 )
- Hex:5 HexNAc:5 dHex:2 (avg mass : 2136.9883 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:4 dHex:2 (avg mass : 2095.9357 )
- Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
- Hex:6 HexNAc:5 NeuAc:2 (avg mass : 2589.3605 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2444.2456 )
- Hex:6 HexNAc:5 dHex:2 (avg mass : 2299.1307 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:12 HexNAc:2 (avg mass : 2370.1141 )
Composition
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
Reference
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
Reported glycosite
- TPLTANITK (9aa)
Mass spectrometry observed peptide
-
- Hex:3 HexNAc:2 dHex:1 / N-Linked
(avg mass : 1056.9755)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:3 HexNAc:3 dHex:1 / N-Linked
(avg mass : 1260.1705)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:3 HexNAc:4 / N-Linked
(avg mass : 1317.2225)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:6 HexNAc:2 / N-Linked
(avg mass : 1397.2597)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:3 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1463.3655)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:3 HexNAc:5 / N-Linked
(avg mass : 1520.4175)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:7 HexNAc:2 / N-Linked
(avg mass : 1559.4021)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:4 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1625.5079)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:3 HexNAc:5 dHex:1 / N-Linked
(avg mass : 1666.5605)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:4 HexNAc:5 / N-Linked
(avg mass : 1682.5599)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:4 HexNAc:3 dHex:1 NeuAc:1 / N-Linked
(avg mass : 1713.5708)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:8 HexNAc:2 / N-Linked
(avg mass : 1721.5445)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:5 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1787.6503)
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:4 HexNAc:5 dHex:1 / N-Linked
(avg mass : 1828.7029)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 1916.7658)
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked
(avg mass : 1932.7652)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:5 HexNAc:5 dHex:1 / N-Linked
(avg mass : 1990.8453)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:4 HexNAc:6 dHex:1 / N-Linked
(avg mass : 2031.8979)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2062.9088)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2078.9082)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:6 HexNAc:4 dHex:2 / N-Linked
(avg mass : 2095.9357)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:4 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2119.9608)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:5 HexNAc:5 NeuAc:1 / N-Linked
(avg mass : 2135.9602)
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:5 HexNAc:5 dHex:2 / N-Linked
(avg mass : 2136.9883)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked
(avg mass : 2224.0231)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:4 HexNAc:5 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2266.1038)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:4 HexNAc:5 NeuAc:1 NeuGc:1 / N-Linked
(avg mass : 2281.0751)
- Urine (UBERON_0001088)
- Prostate cancer (DOID:10283)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2282.1032)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked
(avg mass : 2298.1026)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:6 HexNAc:5 dHex:2 / N-Linked
(avg mass : 2299.1307)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:3 HexNAc:6 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2307.1564)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:12 HexNAc:2 / N-Linked
(avg mass : 2370.1141)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2370.1661)
- Blood Serum (UBERON_0001977)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2444.2456)
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:5 HexNAc:5 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2573.3611)
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
-
- Hex:6 HexNAc:5 NeuAc:2 / N-Linked
(avg mass : 2589.3605)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- TPLTANITK (9aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 NeuAc:2 / N-Linked
(avg mass : 2589.3605)
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:5 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2573.3611)
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2444.2456)
Source
Suggested structure
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked
(avg mass : 2370.1661)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:12 HexNAc:2 / N-Linked
(avg mass : 2370.1141)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:6 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2307.1564)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 dHex:2 / N-Linked
(avg mass : 2299.1307)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:5 NeuAc:1 / N-Linked
(avg mass : 2298.1026)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2282.1032)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:5 NeuAc:1 NeuGc:1 / N-Linked
(avg mass : 2281.0751)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:5 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2266.1038)
Source
Suggested structure
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked
(avg mass : 2224.0231)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:5 dHex:2 / N-Linked
(avg mass : 2136.9883)
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:5 NeuAc:1 / N-Linked
(avg mass : 2135.9602)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:5 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2119.9608)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:4 dHex:2 / N-Linked
(avg mass : 2095.9357)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 2078.9082)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 / N-Linked
(avg mass : 2062.9088)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:6 dHex:1 / N-Linked
(avg mass : 2031.8979)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:5 dHex:1 / N-Linked
(avg mass : 1990.8453)
Source
Suggested structure
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked
(avg mass : 1932.7652)
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 / N-Linked
(avg mass : 1916.7658)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:5 dHex:1 / N-Linked
(avg mass : 1828.7029)
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1787.6503)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:8 HexNAc:2 / N-Linked
(avg mass : 1721.5445)
Source
Suggested structure
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:3 dHex:1 NeuAc:1 / N-Linked
(avg mass : 1713.5708)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:5 / N-Linked
(avg mass : 1682.5599)
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:5 dHex:1 / N-Linked
(avg mass : 1666.5605)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1625.5079)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:2 / N-Linked
(avg mass : 1559.4021)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:5 / N-Linked
(avg mass : 1520.4175)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:4 dHex:1 / N-Linked
(avg mass : 1463.3655)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:2 / N-Linked
(avg mass : 1397.2597)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:4 / N-Linked
(avg mass : 1317.2225)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:3 dHex:1 / N-Linked
(avg mass : 1260.1705)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:2 dHex:1 / N-Linked
(avg mass : 1056.9755)
